Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Albemarle earnings fall but beat estimates
4:05 PM MDT | April 16, 2014 | Vincent Valk
Albemarle today reported net income down 32.6% year-on-year (YOY), to $56.6 million, or 71 cts/share, on net sales up 2.3%, to $656.7 million. Net income fell primarily due to charges related to pension and retiree benefits, while sales rose mostly on higher volumes throughout the company. Excluding the charges, net income declined 7.3% YOY, to $76.7 million, or 96 cts/share, slightly ahead of analysts’ consensus estimate of 95 cts/share, as reported by Thomson Reuters (New York). "Despite the impact of inclement weather on our operations, first...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee